InvestorsObserver
×
News Home

Does Qualigen Therapeutics Inc (QLGN) Have What it Takes to be in Your Portfolio?

Wednesday, February 10, 2021 01:20 PM | InvestorsObserver Analysts

Mentioned in this article

Does Qualigen Therapeutics Inc (QLGN) Have What it Takes to be in Your Portfolio?

The 7 rating InvestorsObserver gives to Qualigen Therapeutics Inc (QLGN) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 4 percent of stocks in the Biotechnology industry, QLGN’s 7 overall rating means the stock scores better than 7 percent of all stocks.

Overall Score - 7
QLGN has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on QLGN!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Qualigen Therapeutics Inc Stock Today?

Qualigen Therapeutics Inc (QLGN) stock is trading at $4.06 as of 1:16 PM on Wednesday, Feb 10, a drop of -$0.07, or -1.69% from the previous closing price of $4.13. The stock has traded between $3.72 and $4.28 so far today. Volume today is 2,370,653 compared to average volume of 2,128,508.

Click Here to get the full Stock Score Report on Qualigen Therapeutics Inc (QLGN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App